메뉴 건너뛰기
Pathology and Oncology Research
Volumn 17, Issue 3, 2011, Pages 443-454
Lymphoproliferative disorders after solid organ transplantation- classification, incidence, risk factors, early detection and treatment options
Author keywords

Adoptive T cell therapy; Early detection; Epstein Barr virus; Immunosuppression; Lymphoma; Posttransplant lymphoproliferative disorders; Risk factors; Rituximab; Solid organ transplantation; Therapy
Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ALPHA INTERFERON; AZATHIOPRINE; BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; DOXORUBICIN; EPSTEIN BARR VIRUS VACCINE; FLUORODEOXYGLUCOSE; GANCICLOVIR; INTERLEUKIN 6; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VALACICLOVIR; VINCRISTINE;
EID: 80052742108     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9329-8     Document Type: Review
Times cited : (89)
References (110)
  • 1
    • 0033056609 scopus 로고    scopus 로고
    • Posttransplant malignancies
    • DOI 10.1016/S0041-1345(98)01987-3, PII S0041134598019873
    • I Penn 1999 Posttransplant malignancies Transplant Proc 31 1260 1262 10083562 1:STN:280:DyaK1M7otlWgsw%3D%3D (Pubitemid 29127895)
    • (1999) Transplantation Proceedings , vol.31 , Issue.1-2 , pp. 1260-1262
    • Penn, I.1
  • 6
    • 0014426044 scopus 로고
    • Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy
    • 4881420 1:STN:280:DyaF1M%2FlsVygsQ%3D%3D
    • PB Doak JZ Montgomerie JD North, et al. 1968 Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy Br Med J 4 746 748 4881420 1:STN:280:DyaF1M%2FlsVygsQ%3D%3D
    • (1968) Br Med J , vol.4 , pp. 746-748
    • Doak, P.B.1    Montgomerie, J.Z.2    North, J.D.3
  • 7
    • 0343171245 scopus 로고
    • Discussion of Murray JE, Wilson RE, Tilney NL et al. Five years' experience in renal transplantation with immunosuppressive drugs: Survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula
    • TE Starzl, et al. 1968 Discussion of Murray JE, Wilson RE, Tilney NL et al. Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula Ann Surg 168 416 435
    • (1968) Ann Surg , vol.168 , pp. 416-435
    • Starzl, T.E.1
  • 8
    • 0015406648 scopus 로고
    • Malignant tumors arising de novo in immunosuppressed organ transplant recipients
    • 4345337 1:STN:280:DyaE3s%2FmslCmtw%3D%3D
    • I Penn TE Starzl 1972 Malignant tumors arising de novo in immunosuppressed organ transplant recipients Transplantation 14 407 4345337 1:STN:280:DyaE3s%2FmslCmtw%3D%3D
    • (1972) Transplantation , vol.14 , pp. 407
    • Penn, I.1    Starzl, T.E.2
  • 9
    • 0016513225 scopus 로고
    • The incidence of malignancies in transplant recipients
    • 1093300 1:STN:280:DyaE2M7mtVequg%3D%3D
    • I Penn 1975 The incidence of malignancies in transplant recipients Transplant Proc 7 323 326 1093300 1:STN:280:DyaE2M7mtVequg%3D%3D
    • (1975) Transplant Proc , vol.7 , pp. 323-326
    • Penn, I.1
  • 10
    • 0021349053 scopus 로고
    • Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
    • TE Starzl MA Nalesnik KA Porter, et al. 1984 Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy Lancet 1 8377 583 587 6142304 1:STN:280:DyaL2c7ktVOntA%3D%3D (Pubitemid 14156511)
    • (1984) Lancet , vol.1 , Issue.8377 , pp. 583-587
    • Starzl, T.E.1    Nalesnik, M.A.2    Porter, K.A.3
  • 11
    • 0033970534 scopus 로고    scopus 로고
    • The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting. Airlie House, Virginia, November 1997
    • 10632755 1:STN:280:DC%2BD3c%2FpvVGrsw%3D%3D
    • NL Harris ES Jaffe J Diebold, et al. 2000 The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting. Airlie House, Virginia, November 1997 Histopathology 36 69 86 10632755 1:STN:280: DC%2BD3c%2FpvVGrsw%3D%3D
    • (2000) Histopathology , vol.36 , pp. 69-86
    • Harris, N.L.1    Jaffe, E.S.2    Diebold, J.3
  • 14
    • 77954344943 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorder in view of the new WHO classification: A more rational approach to a protean disease ?
    • 20576725
    • K Mucha B Foroncewicz B Ziarkiewicz-Wróblewska, et al. 2010 Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease ? Nephrol Dial Transplant 25 2089 2098 20576725
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 2089-2098
    • Mucha, K.1    Foroncewicz, B.2    Ziarkiewicz-Wróblewska, B.3
  • 15
    • 77952718329 scopus 로고    scopus 로고
    • Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients-BCSH and BTS Guidelines
    • 20408847
    • A Parker K Bowles JA Bradley, et al. 2010 Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients-BCSH and BTS Guidelines Br J Haematol 149 675 692 20408847
    • (2010) Br J Haematol , vol.149 , pp. 675-692
    • Parker, A.1    Bowles, K.2    Bradley, J.A.3
  • 16
    • 34547856624 scopus 로고    scopus 로고
    • The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders
    • L Tsao ED Hsi 2007 The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders Arch Pathol Lab Med 131 1209 1218 17683183 (Pubitemid 47257633)
    • (2007) Archives of Pathology and Laboratory Medicine , vol.131 , Issue.8 , pp. 1209-1218
    • Tsao, L.1    Hsi, E.D.2
  • 17
    • 24644495221 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation
    • DOI 10.1016/j.critrevonc.2005.03.015, PII S1040842805000934
    • AL Taylor R Marcus JA Bradley 2005 Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation Crit Rev Oncol Hematol 56 155 167 15979320 (Pubitemid 41278654)
    • (2005) Critical Reviews in Oncology/Hematology , vol.56 , Issue.1 SPEC. ISS. , pp. 155-167
    • Taylor, A.L.1    Marcus, R.2    Bradley, J.A.3
  • 19
    • 0037446832 scopus 로고    scopus 로고
    • Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment
    • SL Guthery JE Heubi JE Bucuvalas, et al. 2003 Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment Transplantation 75 987 993 12698085 1:CAS:528:DC%2BD3sXivFSiu74%3D (Pubitemid 36438527)
    • (2003) Transplantation , vol.75 , Issue.7 , pp. 987-993
    • Guthery, S.L.1    Heubi, J.E.2    Bucuvalas, J.C.3    Gross, T.G.4    Ryckman, F.C.5    Alonso, M.H.6    Balistreri, W.F.7    Hornung, R.W.8
  • 20
    • 1342304173 scopus 로고    scopus 로고
    • Lymphomas after Solid Organ Transplantation: A Collaborative Transplant Study Report
    • DOI 10.1046/j.1600-6143.2003.00325.x
    • G Opelz B Dohler 2004 Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 222 230 14974943 (Pubitemid 38248525)
    • (2004) American Journal of Transplantation , vol.4 , Issue.2 , pp. 222-230
    • Opelz, G.1    Dohler, B.2
  • 21
    • 33846964522 scopus 로고    scopus 로고
    • Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation
    • 17291214 1:CAS:528:DC%2BD2sXjsVyjt7c%3D
    • NA Bakker GW van Imhoff EA Verschuuren, et al. 2007 Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation Transpl Int 20 207 218 17291214 1:CAS:528: DC%2BD2sXjsVyjt7c%3D
    • (2007) Transpl Int , vol.20 , pp. 207-218
    • Bakker, N.A.1    Van Imhoff, G.W.2    Verschuuren, E.A.3
  • 24
    • 0028911721 scopus 로고
    • Pretransplantation seronegative Epstein-Barr virus státusz is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
    • 7779838 1:STN:280:DyaK2M3pvVyjsA%3D%3D
    • RC Walker CV Paya WF Marshall, et al. 1995 Pretransplantation seronegative Epstein-Barr virus státusz is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations J Heart Lung Transplant 14 214 221 7779838 1:STN:280:DyaK2M3pvVyjsA%3D%3D
    • (1995) J Heart Lung Transplant , vol.14 , pp. 214-221
    • Walker, R.C.1    Paya, C.V.2    Marshall, W.F.3
  • 25
    • 28844462295 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorders: Molecular basis of disease histogenesis and pathogenesis
    • DOI 10.1002/hon.751
    • D Capello D Rossi G Gaidano 2005 Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis Hematol Oncol 23 61 67 16216037 (Pubitemid 41774988)
    • (2005) Hematological Oncology , vol.23 , Issue.2 , pp. 61-67
    • Capello, D.1    Rossi, D.2    Gaidano, G.3
  • 26
    • 0037417508 scopus 로고    scopus 로고
    • Simian virus 40 infection in lymphoproliferative disorders [21]
    • DOI 10.1016/S0140-6736(03)12157-5
    • D Capello D Rossi G Gaudino, et al. 2003 Simian virus 40 infection in lymphoproliferative disorders Lancet 36 88 89 (Pubitemid 36050991)
    • (2003) Lancet , vol.361 , Issue.9351 , pp. 88-89
    • Capello, D.1    Rossi, D.2    Gaudino, G.3    Carbone, A.4    Gaidano, G.5
  • 28
    • 0030723580 scopus 로고    scopus 로고
    • Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children
    • DOI 10.1016/S0022-3476(97)70131-8
    • KA Newell EM Alonso SM Kelly, et al. 1997 Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children J Pediatr 131 98 104 9255199 1:STN:280:DyaK2szpvFSksg%3D%3D (Pubitemid 27498316)
    • (1997) Journal of Pediatrics , vol.131 , Issue.1 , pp. 98-104
    • Newell, K.A.1    Alonso, E.M.2    Kelly, S.M.3    Rubin, C.M.4    Thistlethwaite Jr., J.R.5    Whitington, P.F.6
  • 31
    • 0032189676 scopus 로고    scopus 로고
    • BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome
    • E Cesarman A Chadburn YF Liu, et al. 1998 BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome Blood 92 2294 2302 9746767 1:CAS:528:DyaK1cXmsVKgu7c%3D (Pubitemid 28452970)
    • (1998) Blood , vol.92 , Issue.7 , pp. 2294-2302
    • Cesarman, E.1    Chadburn, A.2    Liu, Y.-F.3    Migliazza, A.4    Dalla-Favera, R.5    Knowles, D.M.6
  • 32
    • 32544436112 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities
    • DOI 10.1002/gcc.20287
    • M Djokic MM Le Beau LJ Swinnen, et al. 2006 Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities Genes Chromosom Cancer 45 313 318 16283619 1:CAS:528:DC%2BD28Xht1Ohsb4%3D (Pubitemid 43238481)
    • (2006) Genes Chromosomes and Cancer , vol.45 , Issue.3 , pp. 313-318
    • Djokic, M.1    Le Beau, M.M.2    Swinnen, L.J.3    Smith, S.M.4    Rubin, C.M.5    Anastasi, J.6    Carlson, K.M.7
  • 34
    • 0027501649 scopus 로고
    • Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients
    • DOI 10.1016/S0140-6736(05)80084-4
    • G Opelz R Henderson 1993 Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 8886-8887 1514 1516 7902900 1:STN:280:DyaK2c%2Fns12gsg%3D%3D (Pubitemid 23362168)
    • (1993) Lancet , vol.342 , Issue.8886-8887 , pp. 1514-1516
    • Opelz, G.1    Henderson, R.2
  • 35
    • 0034661894 scopus 로고    scopus 로고
    • The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric transplant patients
    • BS Younes SV McDiarmid MG Martin, et al. 2000 The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients Transplantation 70 94 99 10919581 1:CAS:528: DC%2BD3cXlvVOlsrw%3D (Pubitemid 30490758)
    • (2000) Transplantation , vol.70 , Issue.1 , pp. 94-99
    • Younes, B.S.1    McDiarmid, S.V.2    Martin, M.G.3    Vargas, J.H.4    Goss, J.A.5    Busuttil, R.W.6    Ament, M.E.7
  • 37
    • 0025968958 scopus 로고
    • Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder?
    • 1846454 1:STN:280:DyaK3M7htFCruw%3D%3D
    • SM Cockfield J Preiksaitis E Harvey, et al. 1991 Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplant Proc 23 1106 1107 1846454 1:STN:280:DyaK3M7htFCruw%3D%3D
    • (1991) Transplant Proc , vol.23 , pp. 1106-1107
    • Cockfield, S.M.1    Preiksaitis, J.2    Harvey, E.3
  • 38
    • 28544449370 scopus 로고    scopus 로고
    • Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
    • DOI 10.1097/01.tp.0000179639.98338.39
    • S Caillard V Dharnidharka L Agodoa, et al. 2005 Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression Transplantation 80 1233 1243 16314791 1:CAS:528:DC%2BD2MXht1Gru7nP (Pubitemid 41746802)
    • (2005) Transplantation , vol.80 , Issue.9 , pp. 1233-1243
    • Caillard, S.1    Dharnidharka, V.2    Agodoa, L.3    Bohen, E.4    Abbott, K.5
  • 40
    • 26644443399 scopus 로고    scopus 로고
    • Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
    • DOI 10.1097/01.TP.0000173770.42403.F7
    • BD Kahan YK Yakupoglu L Schoenberg, et al. 2005 Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients Transplantation 80 749 758 16210961 1:CAS:528:DC%2BD2MXhtVynsbvL (Pubitemid 41443756)
    • (2005) Transplantation , vol.80 , Issue.6 , pp. 749-758
    • Kahan, B.D.1    Yakupoglu, Y.K.2    Schoenberg, L.3    Knight, R.J.4    Katz, S.M.5    Lai, D.6    Van Buren, C.T.7
  • 42
    • 33645067673 scopus 로고    scopus 로고
    • Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy
    • 16549120 1:CAS:528:DC%2BD28Xis1aruro%3D
    • YK Yakupoglu JF Buell S Woodle, et al. 2006 Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy Transplant Proc 38 358 361 16549120 1:CAS:528:DC%2BD28Xis1aruro%3D
    • (2006) Transplant Proc , vol.38 , pp. 358-361
    • Yakupoglu, Y.K.1    Buell, J.F.2    Woodle, S.3
  • 43
    • 77954085940 scopus 로고    scopus 로고
    • Treatment advances in posttransplant lymphoproliferative disease
    • 20473161 1:CAS:528:DC%2BC3cXnvVOnsrs%3D
    • CD DiNardo DE Tsai 2010 Treatment advances in posttransplant lymphoproliferative disease Curr Opin Hematol 17 368 374 20473161 1:CAS:528:DC%2BC3cXnvVOnsrs%3D
    • (2010) Curr Opin Hematol , vol.17 , pp. 368-374
    • Dinardo, C.D.1    Tsai, D.E.2
  • 44
    • 33749507195 scopus 로고    scopus 로고
    • Mycophenolate Mofetil and Risk of Developing Malignancy After Orthotopic Heart Transplantation: Analysis of the Transplant Registry of the International Society for Heart and Lung Transplantation
    • DOI 10.1016/j.healun.2006.06.010, PII S105324980600489X
    • JO O'Neill LB Edwards DO Taylor 2006 Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 25 1186 1191 17045930 (Pubitemid 44528284)
    • (2006) Journal of Heart and Lung Transplantation , vol.25 , Issue.10 , pp. 1186-1191
    • O'Neill, J.O.1    Edwards, L.B.2    Taylor, D.O.3
  • 45
    • 33644821539 scopus 로고    scopus 로고
    • Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil
    • DOI 10.1111/j.1600-6143.2005.01125.x
    • R Robson JM Cecka G Opelz, et al. 2005 Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil Am J Transplant 5 2954 2960 16303010 1:STN:280:DC%2BD2MnitFKlsA%3D%3D (Pubitemid 43923957)
    • (2005) American Journal of Transplantation , vol.5 , Issue.12 , pp. 2954-2960
    • Robson, R.1    Cecka, J.M.2    Opelz, G.3    Budde, M.4    Sacks, S.5
  • 46
    • 28544450172 scopus 로고    scopus 로고
    • Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil
    • DOI 10.1097/01.tp.0000169035.10572.c6
    • DP Funch HH Ko J Travasso, et al. 2005 Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil Transplantation 80 1174 1180 16314782 (Pubitemid 41746793)
    • (2005) Transplantation , vol.80 , Issue.9 , pp. 1174-1180
    • Funch, D.P.1    Hnin, H.K.2    Travasso, J.3    Brady, J.4    Kew II, C.E.5    Nalesnik, M.A.6    Walker, A.M.7
  • 47
    • 76949090842 scopus 로고    scopus 로고
    • A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)
    • 20415898 1:CAS:528:DC%2BC3cXkt1ahtL8%3D
    • A Durrbach JM Pestana T Pearson, et al. 2010 A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study) Am J Transplant 10 547 557 20415898 1:CAS:528:DC%2BC3cXkt1ahtL8%3D
    • (2010) Am J Transplant , vol.10 , pp. 547-557
    • Durrbach, A.1    Pestana, J.M.2    Pearson, T.3
  • 48
    • 34250156714 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors
    • J Pascual 2007 Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors Nephrol Dial Transplant 22 27 35
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 27-35
    • Pascual, J.1
  • 49
    • 36148981135 scopus 로고    scopus 로고
    • B lymphocytes and Epstein-Barr virus: The lesson of post-transplant lymphoproliferative disorders
    • DOI 10.1016/j.autrev.2007.02.012, PII S1568997207000572, B Cell Targeted Therapies
    • R Dolcetti 2007 B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders Autoimmun Rev 7 96 101 18035317 1:CAS:528:DC%2BD1cXhtVKjsrY%3D (Pubitemid 350116719)
    • (2007) Autoimmunity Reviews , vol.7 , Issue.2 , pp. 96-101
    • Dolcetti, R.1
  • 50
    • 45749107592 scopus 로고    scopus 로고
    • EBV-associated lymphoproliferative disorders: Classification and treatment
    • DOI 10.1634/theoncologist.2008-0036
    • A Carbone A Gloghini G Dotti 2008 EBV-associated lymphoproliferative disorders: classification and treatment Oncologist 13 577 585 18515742 (Pubitemid 351872874)
    • (2008) Oncologist , vol.13 , Issue.5 , pp. 577-585
    • Carbone, A.1    Gloghini, A.2    Dotti, G.3
  • 51
    • 33846217750 scopus 로고    scopus 로고
    • Epstein-Barr virus: Evasive maneuvers in the development of PTLD
    • DOI 10.1111/j.1600-6143.2006.01650.x
    • AL Snow OM Martinez 2007 Epstein-Barr virus: evasive maneuvers in the development of PTLD Am J Transplant 7 271 277 17229074 1:CAS:528: DC%2BD2sXhvFClsb8%3D (Pubitemid 46096319)
    • (2007) American Journal of Transplantation , vol.7 , Issue.2 , pp. 271-277
    • Snow, A.L.1    Martinez, O.M.2
  • 53
    • 0036435166 scopus 로고    scopus 로고
    • Epstein-Barr virus in the pathogenesis of NPC
    • DOI 10.1016/S1044579X0200086X
    • N Raab-Traub 2002 Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 12 431 441 12450729 1:CAS:528:DC%2BD38Xosl2gu7o%3D (Pubitemid 35370756)
    • (2002) Seminars in Cancer Biology , vol.12 , Issue.6 , pp. 431-441
    • Raab-Traub, N.1
  • 54
    • 0038121814 scopus 로고    scopus 로고
    • Epstein-Barr virus: Induction and control of cell transformation
    • DOI 10.1002/jcp.10263
    • R Dolcetti MG Masucci 2003 Epstein-Barr virus: induction and control of cell transformation J Cell Physiol 196 207 218 12811813 1:CAS:528: DC%2BD3sXltlSmsLk%3D (Pubitemid 36775867)
    • (2003) Journal of Cellular Physiology , vol.196 , Issue.2 , pp. 207-218
    • Dolcetti, R.1    Masucci, M.G.2
  • 55
    • 33750839308 scopus 로고    scopus 로고
    • The role of Epstein-Barr virus in cancer
    • 17049016 1:CAS:528:DC%2BD28XhtVyqtr7L
    • SB Pattle PJ Farrel 2006 The role of Epstein-Barr virus in cancer Expert Opin Biol Ther 6 1193 1205 17049016 1:CAS:528:DC%2BD28XhtVyqtr7L
    • (2006) Expert Opin Biol Ther , vol.6 , pp. 1193-1205
    • Pattle, S.B.1    Farrel, P.J.2
  • 59
    • 0028815349 scopus 로고
    • Central nervous system lymphomas in organ allograft recipients
    • 7839447 1:STN:280:DyaK2M7ktFeqsg%3D%3D
    • I Penn G Porat 1995 Central nervous system lymphomas in organ allograft recipients Transplantation 59 240 244 7839447 1:STN:280:DyaK2M7ktFeqsg%3D%3D
    • (1995) Transplantation , vol.59 , pp. 240-244
    • Penn, I.1    Porat, G.2
  • 61
    • 0034805304 scopus 로고    scopus 로고
    • Lymphoproliferative disease after lung transplantation: Comparison of presentation and outcome of early and late cases
    • DOI 10.1016/S1053-2498(01)00314-X, PII S105324980100314X
    • S Paranjothi RD Yusen MD Kraus, et al. 2001 Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases J Heart Lung Transplant 20 1054 1063 11595560 1:STN:280: DC%2BD3MrkvFSntQ%3D%3D (Pubitemid 32930110)
    • (2001) Journal of Heart and Lung Transplantation , vol.20 , Issue.10 , pp. 1054-1063
    • Paranjothi, S.1    Yusen, R.D.2    Kraus, M.D.3    Lynch, J.P.4    Patterson, G.A.5    Trulock, E.P.6
  • 62
    • 0028296089 scopus 로고
    • Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease
    • A Savoie C Perpete L Carpentier, et al. 1994 Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease Blood 83 2715 2722 8167350 1:STN:280:DyaK2c3itVOiuw%3D%3D (Pubitemid 24135866)
    • (1994) Blood , vol.83 , Issue.9 , pp. 2715-2722
    • Savoie, A.1    Perpete, C.2    Carpentier, L.3    Joncas, J.4    Alfieri, C.5
  • 63
    • 0028356401 scopus 로고
    • Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
    • 8043879 1:STN:280:DyaK2czhvV2kuw%3D%3D
    • SA Riddler MC Breinig JL McKnight 1994 Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients Blood 84 972 984 8043879 1:STN:280:DyaK2czhvV2kuw%3D%3D
    • (1994) Blood , vol.84 , pp. 972-984
    • Riddler, S.A.1    Breinig, M.C.2    McKnight, J.L.3
  • 64
    • 33644887736 scopus 로고    scopus 로고
    • American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation
    • DOI 10.1111/j.1600-6143.2005.01207.x
    • A Humar M Michaels 2006 AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation Am J Transplant 6 262 274 16426310 1:STN:280:DC%2BD28%2FjvVCjug%3D%3D (Pubitemid 43382161)
    • (2006) American Journal of Transplantation , vol.6 , Issue.2 , pp. 262-274
    • Humar, A.1    Michaels, M.2
  • 65
    • 0037407860 scopus 로고    scopus 로고
    • Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler
    • DOI 10.1016/S0166-0934(03)00076-4
    • S Patel M Zuckerman M Smith 2003 Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler J Virol Meth 109 227 233 1:CAS:528:DC%2BD3sXjtFWrsLc%3D (Pubitemid 36507112)
    • (2003) Journal of Virological Methods , vol.109 , Issue.2 , pp. 227-233
    • Patel, S.1    Zuckerman, M.2    Smith, M.3
  • 66
    • 2342535118 scopus 로고    scopus 로고
    • Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma
    • DOI 10.1016/j.jcv.2003.10.002, PII S1386653203002828
    • S Fafi-Kremer K Brengel-Pesce G Bargues, et al. 2004 Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma J Clin Virol 30 157 164 15125872 1:CAS:528:DC%2BD2cXjs1ejt7o%3D (Pubitemid 38582023)
    • (2004) Journal of Clinical Virology , vol.30 , Issue.2 , pp. 157-164
    • Fafi-Kremer, S.1    Brengel-Pesce, K.2    Bargues, G.3    Bourgeat, M.-J.4    Genoulaz, O.5    Seigneurin, J.-M.6    Morand, P.7
  • 67
    • 0035960056 scopus 로고    scopus 로고
    • Patients at risk for development of posttransplant lymphoproliferative disorder: Plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction
    • HJ Wagner M Wessel W Jabs, et al. 2001 Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction Transplantation 72 1012 1019 11579293 1:STN:280:DC%2BD3Mrjt1OksA%3D%3D (Pubitemid 32924070)
    • (2001) Transplantation , vol.72 , Issue.6 , pp. 1012-1019
    • Wagner, H.-J.1    Wessel, M.2    Jabs, W.3    Smets, F.4    Fischer, L.5    Offner, G.6    Bucsky, P.7
  • 69
    • 53149114141 scopus 로고    scopus 로고
    • Quantitative Epstein- Barr virus viral load monitoring in pediatric liver transplantation
    • 18929796 1:STN:280:DC%2BD1cnnt1CmtQ%3D%3D
    • JY Jang KM Kim YJ Lee, et al. 2008 Quantitative Epstein- Barr virus viral load monitoring in pediatric liver transplantation Transplant Proc 40 2546 2548 18929796 1:STN:280:DC%2BD1cnnt1CmtQ%3D%3D
    • (2008) Transplant Proc , vol.40 , pp. 2546-2548
    • Jang, J.Y.1    Kim, K.M.2    Lee, Y.J.3
  • 70
    • 70349663887 scopus 로고    scopus 로고
    • Target monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
    • 19497070 1:STN:280:DC%2BD1MnmvVekug%3D%3D
    • H Omar H Hägglund Å Gustafsson-Jernberg, et al. 2009 Target monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction Transpl Infect Dis 11 393 399 19497070 1:STN:280:DC%2BD1MnmvVekug%3D%3D
    • (2009) Transpl Infect Dis , vol.11 , pp. 393-399
    • Omar, H.1    Hägglund, H.2    Gustafsson-Jernberg, A.3
  • 71
    • 0037182156 scopus 로고    scopus 로고
    • Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease
    • F Smets D Latinne H Bazin, et al. 2002 Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease Transplantation 73 1603 1610 12042647 (Pubitemid 34568673)
    • (2002) Transplantation , vol.73 , Issue.10 , pp. 1603-1610
    • Smets, F.1    Latinne, D.2    Bazin, H.3    Reding, R.4    Otte, J.-B.5    Buts, J.-P.6    Sokal, E.M.7
  • 72
    • 40849118174 scopus 로고    scopus 로고
    • Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease
    • DOI 10.1097/TP.0b013e3181661676, PII 0000789020080315000010
    • E Bianchi M Pascual M Nicod, et al. 2008 Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease Transplantation 85 707 712 18337664 (Pubitemid 351398247)
    • (2008) Transplantation , vol.85 , Issue.5 , pp. 707-712
    • Bianchi, E.1    Pascual, M.2    Nicod, M.3    Delaloye, A.B.4    Duchosal, M.A.5
  • 73
    • 77952630793 scopus 로고    scopus 로고
    • Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients-BCSH and BTS Guidelines
    • 20408848
    • A Parker K Bowles JA Bradley, et al. 2010 Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients-BCSH and BTS Guidelines Br J Haematol 149 693 705 20408848
    • (2010) Br J Haematol , vol.149 , pp. 693-705
    • Parker, A.1    Bowles, K.2    Bradley, J.A.3
  • 74
    • 0033610627 scopus 로고    scopus 로고
    • Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting
    • 10589949 1:STN:280:DC%2BD3c%2FlsFyqtg%3D%3D
    • CV Paya JJ Fung MA Nalesnik, et al. 1999 Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting Transplantation 68 1517 1525 10589949 1:STN:280:DC%2BD3c%2FlsFyqtg%3D%3D
    • (1999) Transplantation , vol.68 , pp. 1517-1525
    • Paya, C.V.1    Fung, J.J.2    Nalesnik, M.A.3
  • 75
    • 0032717367 scopus 로고    scopus 로고
    • The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients
    • DOI 10.1034/j.1399-3046.1999.00066.x
    • M Green MG Michaels SA Webber, et al. 1999 The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients Pediatr Transplant 3 271 281 10562971 1:STN:280:DC%2BD3c%2FivVOisw%3D%3D (Pubitemid 29503271)
    • (1999) Pediatric Transplantation , vol.3 , Issue.4 , pp. 271-281
    • Green, M.1    Michaels, M.G.2    Webber, S.A.3    Rowe, D.4    Reyes, J.5
  • 76
    • 14544302778 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorders
    • DOI 10.1146/annurev.med.56.082103.104727
    • S Gottschalk CM Rooney HE Heslop 2005 Post-transplant lymphoproliferative disorders Annu Rev Med 56 29 44 15660500 1:CAS:528:DC%2BD2MXisVSrsLs%3D (Pubitemid 40299772)
    • (2005) Annual Review of Medicine , vol.56 , pp. 29-44
    • Gottschalk, S.1    Rooney, C.M.2    Heslop, H.E.3
  • 80
    • 70350569195 scopus 로고    scopus 로고
    • Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation
    • 19669857
    • H Ohta N Fukushima K Ozono 2009 Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation Int J Hematol 90 127 136 19669857
    • (2009) Int J Hematol , vol.90 , pp. 127-136
    • Ohta, H.1    Fukushima, N.2    Ozono, K.3
  • 81
    • 0033997255 scopus 로고    scopus 로고
    • Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
    • 10707791
    • N Milpied B Vasseur N Parquet, et al. 2000 Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients Ann Oncol 11 113 116 10707791
    • (2000) Ann Oncol , vol.11 , pp. 113-116
    • Milpied, N.1    Vasseur, B.2    Parquet, N.3
  • 83
    • 70349219929 scopus 로고    scopus 로고
    • Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression
    • 19663889 1:CAS:528:DC%2BD1MXhtlWlurrI
    • R Trappe C Hinrichs U Appel, et al. 2009 Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression Am J Transplant 9 2331 2337 19663889 1:CAS:528: DC%2BD1MXhtlWlurrI
    • (2009) Am J Transplant , vol.9 , pp. 2331-2337
    • Trappe, R.1    Hinrichs, C.2    Appel, U.3
  • 85
    • 7744234339 scopus 로고    scopus 로고
    • Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease
    • DOI 10.1016/j.beha.2004.05.007, PII S1521692604000416
    • HE Heslop B Savoldo CM Rooney 2004 Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease Best Pract Res Clin Haematol 17 401 413 15498712 1:CAS:528:DC%2BD2cXovVKlsbg%3D (Pubitemid 39462572)
    • (2004) Best Practice and Research: Clinical Haematology , vol.17 , Issue.3 SPEC.ISS. , pp. 401-413
    • Heslop, H.E.1    Savoldo, B.2    Rooney, C.M.3
  • 87
    • 0032406790 scopus 로고    scopus 로고
    • CD20-negative relapse in B-cell lymphoma after treatment with Rituximab [1]
    • T Kinoshita H Nagai T Murate, et al. 1998 CD-20-negative relapse in B-cell lymphoma after treatment with Rituximab J Clin Oncol 16 3916 9850038 1:STN:280:DyaK1M%2FmsFaqsg%3D%3D (Pubitemid 29001546)
    • (1998) Journal of Clinical Oncology , vol.16 , Issue.12 , pp. 3916
    • Kinoshita, T.1    Nagai, H.2    Murate, T.3    Saito, H.4
  • 88
    • 33645740570 scopus 로고    scopus 로고
    • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: Results of a prospective multicenter phase 2 study
    • 16254143 1:CAS:528:DC%2BD28Xjs1Olurs%3D
    • S Choquet V Leblond R Herbrecht, et al. 2006 Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study Blood 107 3053 3057 16254143 1:CAS:528:DC%2BD28Xjs1Olurs%3D
    • (2006) Blood , vol.107 , pp. 3053-3057
    • Choquet, S.1    Leblond, V.2    Herbrecht, R.3
  • 89
    • 0028816546 scopus 로고
    • Use of gene-modified virus specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation
    • 7799740 1:STN:280:DyaK2M%2FpslOgsA%3D%3D
    • CM Rooney CA Smith CY Ng, et al. 1995 Use of gene-modified virus specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation Lancet 345 9 13 7799740 1:STN:280:DyaK2M%2FpslOgsA%3D%3D
    • (1995) Lancet , vol.345 , pp. 9-13
    • Rooney, C.M.1    Smith, C.A.2    Ng, C.Y.3
  • 91
    • 0346121400 scopus 로고    scopus 로고
    • Tumors and Transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium
    • DOI 10.1046/j.1600-6143.2003.00245.x
    • S Feng JF Buell RS Chari, et al. 2003 Tumors and transplantation : the 2003 third annual ASTS state-of-the-art winter symposium Am J Transplant 3 1481 1487 14629278 (Pubitemid 37541505)
    • (2003) American Journal of Transplantation , vol.3 , Issue.12 , pp. 1481-1487
    • Feng, S.1    Buell, J.F.2    Chari, R.S.3    DiMaio, J.M.4    Hanto, D.W.5
  • 92
    • 0037055714 scopus 로고    scopus 로고
    • Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
    • DOI 10.1016/S0140-6736(02)09672-1
    • T Haque GM Wilkie C Taylor, et al. 2002 Treatment of Epstein-Barr-virus- positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells Lancet 360 9331 436 442 12241714 (Pubitemid 34880139)
    • (2002) Lancet , vol.360 , Issue.9331 , pp. 436-442
    • Haque, T.1    Wilkie, G.M.2    Taylor, C.3    Amlot, P.L.4    Murad, P.5    Iley, A.6    Dombagoda, D.7    Britton, K.M.8    Swerdlow, A.J.9    Crawford, D.H.10
  • 94
    • 0041835914 scopus 로고    scopus 로고
    • Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine
    • 12973121 1:CAS:528:DC%2BD3sXoslGltLg%3D
    • X Zhan B Brown KS Slobod, et al. 2003 Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine Transplantation 76 739 740 12973121 1:CAS:528:DC%2BD3sXoslGltLg%3D
    • (2003) Transplantation , vol.76 , pp. 739-740
    • Zhan, X.1    Brown, B.2    Slobod, K.S.3
  • 95
    • 74049116602 scopus 로고    scopus 로고
    • Generation of EBV-specific cytotoxic T-cells that are resistant to calcineurin inhibitors for the treatment of post-transplant lymphoproliferative disease
    • 19770360 1:CAS:528:DC%2BD1MXhsFGqsbzO
    • J Brewin C Mancao K Straathof, et al. 2009 Generation of EBV-specific cytotoxic T-cells that are resistant to calcineurin inhibitors for the treatment of post-transplant lymphoproliferative disease Blood 114 4792 4803 19770360 1:CAS:528:DC%2BD1MXhsFGqsbzO
    • (2009) Blood , vol.114 , pp. 4792-4803
    • Brewin, J.1    Mancao, C.2    Straathof, K.3
  • 96
    • 0032573751 scopus 로고    scopus 로고
    • Interferon-α treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants
    • DOI 10.1097/00007890-199812270-00035
    • Davis CL BL Wood DE Sabath, et al. 1998 Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants Transplantation 66 1770 1779 9884275 (Pubitemid 29035007)
    • (1998) Transplantation , vol.66 , Issue.12 , pp. 1770-1779
    • Davis, C.L.1    Wood, B.L.2    Sabath, D.E.3    Joseph, J.S.4    Stehman-Breen, C.5    Broudy, V.C.6
  • 97
    • 1642482870 scopus 로고    scopus 로고
    • Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies
    • DOI 10.1111/j.0001-2815.2004.00227.x
    • JE Davis DJ Moss 2004 Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies Tissue Antigens 63 285 292 15009802 1:STN:280: DC%2BD2c7itVOgtg%3D%3D (Pubitemid 38406691)
    • (2004) Tissue Antigens , vol.63 , Issue.4 , pp. 285-292
    • Davis, J.E.1    Moss, D.J.2
  • 100
    • 4744340509 scopus 로고    scopus 로고
    • New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients
    • DOI 10.1086/424447
    • JK Preiksaitis 2004 New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients Clin Infect Dis 39 1016 1023 15472855 (Pubitemid 39313460)
    • (2004) Clinical Infectious Diseases , vol.39 , Issue.7 , pp. 1016-1023
    • Preiksaitis, J.K.1
  • 101
    • 31744433895 scopus 로고    scopus 로고
    • Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients
    • DOI 10.1111/j.1600-6143.2005.01115.x
    • DP Funch AM Walker G Schneider, et al. 2005 Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients Am J Transplant 5 2894 2900 16303002 1:STN:280: DC%2BD2MnitFKmtg%3D%3D (Pubitemid 43923949)
    • (2005) American Journal of Transplantation , vol.5 , Issue.12 , pp. 2894-2900
    • Funch, D.P.1    Walker, A.M.2    Schneider, G.3    Ziyadeh, N.J.4    Pescovitz, M.D.5
  • 103
    • 33847136032 scopus 로고    scopus 로고
    • Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: A multicentre retrospective analysis
    • DOI 10.1016/S1470-2045(07)70040-2, PII S1470204507700402
    • G Opelz V Daniel C Naujokat, et al. 2007 Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma:a multicentre retrospective analysis Lancet Oncol 8 212 218 17329191 1:CAS:528:DC%2BD2sXisVCqsrc%3D (Pubitemid 46291703)
    • (2007) Lancet Oncology , vol.8 , Issue.3 , pp. 212-218
    • Opelz, G.1    Daniel, V.2    Naujokat, C.3    Fickenscher, H.4    Dohler, B.5
  • 104
    • 0029188184 scopus 로고
    • First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen
    • 7796951 1:STN:280:DyaK2MzhslCluw%3D%3D
    • SY Gu TM Huang L Ruan, et al. 1995 First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen Dev Biol Stand 84 171 177 7796951 1:STN:280:DyaK2MzhslCluw%3D%3D
    • (1995) Dev Biol Stand , vol.84 , pp. 171-177
    • Gu, S.Y.1    Huang, T.M.2    Ruan, L.3
  • 105
    • 65549109759 scopus 로고    scopus 로고
    • Immunization and transplantation-what is new and what is coming?
    • 19032408 1:CAS:528:DC%2BD1MXmvFyisrg%3D
    • KM Posfay-Barbe CA Siegrist 2009 Immunization and transplantation-what is new and what is coming? Pediatr Transplant 13 404 410 19032408 1:CAS:528:DC%2BD1MXmvFyisrg%3D
    • (2009) Pediatr Transplant , vol.13 , pp. 404-410
    • Posfay-Barbe, K.M.1    Siegrist, C.A.2
  • 106
    • 0042090489 scopus 로고    scopus 로고
    • Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas
    • RR Nepomuceno CE Balatoni Y Natkunam, et al. 2003 Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas Cancer Res 63 4472 4480 12907620 1:CAS:528:DC%2BD3sXmtFersrg%3D (Pubitemid 36951019)
    • (2003) Cancer Research , vol.63 , Issue.15 , pp. 4472-4480
    • Nepomuceno, R.R.1    Balatoni, C.E.2    Natkunam, Y.3    Snow, A.L.4    Krams, S.M.5    Martinez, O.M.6
  • 107
    • 68949203528 scopus 로고    scopus 로고
    • Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab
    • 19715944 1:CAS:528:DC%2BD1MXhtVKmurfJ
    • S Alexandru E Gonzalez C Grande, et al. 2009 Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab Transplant Proc 41 2435 2437 19715944 1:CAS:528:DC%2BD1MXhtVKmurfJ
    • (2009) Transplant Proc , vol.41 , pp. 2435-2437
    • Alexandru, S.1    Gonzalez, E.2    Grande, C.3
  • 108
    • 65549088504 scopus 로고    scopus 로고
    • Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: Role of mycophenolate mofetil
    • 19300188 1:CAS:528:DC%2BD1MXjtlOqs70%3D
    • MV Holmes B Caplin C Atkinson, et al. 2009 Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil Transplantation 87 852 856 19300188 1:CAS:528:DC%2BD1MXjtlOqs70%3D
    • (2009) Transplantation , vol.87 , pp. 852-856
    • Holmes, M.V.1    Caplin, B.2    Atkinson, C.3
  • 109
    • 34249891363 scopus 로고    scopus 로고
    • Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas
    • DOI 10.1016/j.leukres.2006.12.019, PII S0145212607000057
    • G Vegso A Sebestyen S Paku, et al. 2007 Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas Leuk Res 31 1003 1008 17320952 1:CAS:528:DC%2BD2sXmtlamsrc%3D (Pubitemid 46863465)
    • (2007) Leukemia Research , vol.31 , Issue.7 , pp. 1003-1008
    • Vegso, G.1    Sebestyen, A.2    Paku, S.3    Barna, G.4    Hajdu, M.5    Toth, M.6    Jaray, J.7    Kopper, L.8
  • 110
    • 33644983882 scopus 로고    scopus 로고
    • IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells
    • 16505121 1:CAS:528:DC%2BD28XhvVelsbs%3D
    • N Takebe X Cheng TE Fandy, et al. 2006 IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells Mol Cancer Ther 5 457 466 16505121 1:CAS:528:DC%2BD28XhvVelsbs%3D
    • (2006) Mol Cancer Ther , vol.5 , pp. 457-466
    • Takebe, N.1    Cheng, X.2    Fandy, T.E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.